Retrieved on:
Tuesday, February 13, 2024
OR YEHUDA, Israel and RAANANA, Israel, Feb. 13, 2024 /PRNewswire/ -- PatenSee, developer of a fistula monitoring system for dialysis patients, has entered into an agreement with Fresenius Medical Care, a leading global provider of dialysis services.
Key Points:
- OR YEHUDA, Israel and RAANANA, Israel, Feb. 13, 2024 /PRNewswire/ -- PatenSee, developer of a fistula monitoring system for dialysis patients, has entered into an agreement with Fresenius Medical Care, a leading global provider of dialysis services.
- Under the agreement, the parties will first collaborate in a joint, multi-center, pilot trial of PatenSee's contactless monitoring system in Fresenius Medical Care's dialysis clinics in Israel.
- "Timely monitoring and analysis of the fistula status of hemodialysis patients are major clinical unmet needs and PatenSee's contactless, rapid monitoring has the potential to make a significant impact in dialysis patients," said Adi Shaked, Venture Innovation Manager-Israel at Fresenius Medical Care, which is leading the collaboration from the Fresenius Medical Care Ventures team, along with Dr. Alon Antebi, country medical director at Fresenius Medical Care, Israel.
- We are happy to start this new phase of implementing PatenSee's contactless monitoring technology and even happier to perform this study in collaboration with Fresenius Medical Care with its wealth of experience and clinical expertise," said Shai Policker, chairman of PatenSee.
Retrieved on:
Wednesday, September 20, 2023
Ottawa Hospital Research Institute,
David Geffen School of Medicine at UCLA,
National Kidney Foundation,
Rockwell Medical,
Kidney failure,
University,
Emeritus,
Stenosis,
Teaching,
Physician,
Renal replacement therapy,
Coronavirus Scientific Advisory Board,
Research,
Mentorship,
Associate,
University Health Network,
Dialysis,
ASN,
Patient,
NKF,
Nursing,
DaVita Inc.,
Kidney,
Renal Physicians Association,
Reading,
BPS Barbara Wilson Lifetime Achievement Award,
ISCB Senior Scientist Award,
Vascular access,
UCLA,
Therapy,
Conference,
Chronic kidney disease,
Kidney disease,
Award,
Fistula,
Medical device,
Pharmaceutical industry,
Medicine OR YEHUDA, Israel, Sept. 20, 2023 /PRNewswire/ -- Dr. Charmaine Lok is the new Chairperson of the PatenSee Scientific Advisory Board. The company also announced today that Dr. Allen R. Nissenson has joined the company as a strategic advisor. PatenSee is developing a contactless imaging system to provide rapid vascular access monitoring for hemodialysis patients.
Key Points:
- OR YEHUDA, Israel, Sept. 20, 2023 /PRNewswire/ -- Dr. Charmaine Lok is the new Chairperson of the PatenSee Scientific Advisory Board.
- The company also announced today that Dr. Allen R. Nissenson has joined the company as a strategic advisor.
- I am delighted to join PatenSee as the chairperson of its Scientific Advisory Board and look forward to guiding this technology's further development to rapidly make it available for improving patient outcomes," said Dr. Lok.
- Dr. Nissenson currently serves on the Board of Directors of Elicio Therapeutics, Rockwell Medical, Innocura Nephrology and Diality Inc.
